135 related articles for article (PubMed ID: 27061518)
1. FDA approves new treatment of metastatic melanoma.
Printz C
Cancer; 2016 Apr; 122(8):1149. PubMed ID: 27061518
[No Abstract] [Full Text] [Related]
2. [Immunotherapy in the treatment of advanced or metastatic melanoma: nivolumab from phase I studies to approvement by European Medicines Agency].
Queirolo P; Tanda ET
Recenti Prog Med; 2015 Dec; 106(12):608-17. PubMed ID: 26780070
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous melanoma: available therapy for metastatic disease.
Tarhini AA; Agarwala SS
Dermatol Ther; 2006; 19(1):19-25. PubMed ID: 16405566
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on pembrolizumab in the treatment of advanced melanoma.
Rajakulendran T; Adam DN
Drug Des Devel Ther; 2015; 9():2883-6. PubMed ID: 26082618
[TBL] [Abstract][Full Text] [Related]
5. Melanoma treatment's changing landscape.
Jenks S
J Natl Cancer Inst; 2014 Jun; 106(6):dju176. PubMed ID: 24907389
[No Abstract] [Full Text] [Related]
6. High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma.
Garnier M; Zaragoza J; Bénéton N; Bens G; Meurisse V; Samimi M; Maillard H; Machet L
J Am Acad Dermatol; 2018 Jul; 79(1):165-167.e2. PubMed ID: 29544740
[No Abstract] [Full Text] [Related]
7. Ipilimumab approved for metastatic melanoma.
Traynor K
Am J Health Syst Pharm; 2011 May; 68(9):768. PubMed ID: 21515855
[No Abstract] [Full Text] [Related]
8. FDA approves new melanoma treatments.
Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):3. PubMed ID: 22396993
[No Abstract] [Full Text] [Related]
9. FDA approves two new drugs against advanced melanoma.
Thompson CA
Am J Health Syst Pharm; 2013 Jul; 70(13):1094. PubMed ID: 23784149
[No Abstract] [Full Text] [Related]
10. NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma.
Hall CJ; Doss S; Robertson J; Adam J
Lancet Oncol; 2014 Sep; 15(10):1056-7. PubMed ID: 25328937
[No Abstract] [Full Text] [Related]
11. New therapeutical strategies in the treatment of metastatic disease.
Julia F; Thomas L; Dalle S
Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
[TBL] [Abstract][Full Text] [Related]
12. Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
Margolin KA
Cancer; 2004 Aug; 101(3):435-8. PubMed ID: 15274056
[No Abstract] [Full Text] [Related]
13. [Treatment of metastasized malignant melanoma].
Kamanabrou D
Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
[TBL] [Abstract][Full Text] [Related]
14. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
15. NICE approves immunotherapy combination for advanced melanoma.
Wise J
BMJ; 2016 Jun; 353():i3421. PubMed ID: 27317590
[No Abstract] [Full Text] [Related]
16. Successes and setbacks of early investigational drugs for melanoma.
Orloff M; Valsecchi ME; Sato T
Expert Opin Investig Drugs; 2015; 24(8):993-7. PubMed ID: 26068553
[TBL] [Abstract][Full Text] [Related]
17. Intralesional therapy as a treatment for locoregionally metastatic melanoma.
Miura JT; Zager JS
Expert Rev Anticancer Ther; 2018 Apr; 18(4):399-408. PubMed ID: 29466885
[TBL] [Abstract][Full Text] [Related]
18. Reaching first base in the treatment of metastatic melanoma.
Eggermont AM
J Clin Oncol; 2006 Oct; 24(29):4673-4. PubMed ID: 16966683
[No Abstract] [Full Text] [Related]
19. Future Directions and Challenges Facing Intralesional Immunotherapy With Talimogene Laherparepvec for Advanced Melanoma.
Queen D; Samie FH; Zeitouni NC
Dermatol Surg; 2021 Jan; 47(1):132-133. PubMed ID: 31574028
[No Abstract] [Full Text] [Related]
20. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
